| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;36:600.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Trends in Antihypertensive Drug Therapy of Ambulatory Patients by US Office-Based Physicians
From the Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, National Institutes of Health (C.R.N.), Bethesda, Md, and the Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland (D.A.K.), Baltimore, Md.
Correspondence to Cheryl Nelson, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, National Institutes of Health, 2 Rockledge Centre, 6701 Rockledge Dr, Room 8152, Bethesda, MD 20892-7934. E-mail cn80n{at}nih.gov
Abstract—This study assessed trends from 1980 to 1995 in ambulatory patients’ antihypertensive drug therapy by US office-based physicians for visits in which hypertension was the principal diagnosis and compared these trends with the respective guidelines given in 5 Joint National Committee (JNC) Reports on Detection, Evaluation, and Treatment of High Blood Pressure published around the same time period. Data from the National Center for Health Statistics’ National Ambulatory Medical Care Surveys for 1980, 1985, 1990, and 1995 were used. From 1980 to 1995, there was no significant trend in the percentage of hypertension visits that did not mention any antihypertensive drug (20% to 27%). Further analyses focused on those hypertension visits in which at least 1 antihypertensive drug was used. Across the years, antihypertensive drug visits mentioning calcium channel blockers or ACE inhibitors significantly increased; those noting diuretics significantly decreased. However, in 1995, antihypertensive drug visits that included a diuretic and/or a ß-adrenergic blocker equalled 53%; these are the antihypertensive drug classes preferred by the JNC V. Physician antihypertensive drug prescribing was generally consistent with the basic antihypertensive drug guidelines of the JNC reports.
Key Words: antihypertensive agents • hypertension, essential • drug therapy
This article has been cited by other articles:
 |
|
 |
|
  M.A.C. Onuigbo Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontarget--a call for more circumspection QJM, March 1, 2009; 102(3): 155 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.A.C. Onuigbo and N.T.C. Onuigbo Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis QJM, July 1, 2008; 101(7): 519 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Keyhani, J. V. Scobie, P. L. Hebert, and M. A. McLaughlin Gender Disparities in Blood Pressure Control and Cardiovascular Care in a National Sample of Ambulatory Care Visits Hypertension, April 1, 2008; 51(4): 1149 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Stafford, V. Monti, C. D. Furberg, and J. Ma Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United States Hypertension, August 1, 2006; 48(2): 213 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Kotchen From Clinical Trials to Clinical Practice: Why the Gap? Hypertension, August 1, 2006; 48(2): 196 - 197. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Gu, R. Paulose-Ram, C. Dillon, and V. Burt Antihypertensive Medication Use Among US Adults With Hypertension Circulation, January 17, 2006; 113(2): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buzdar and C. Macahilig How Rapidly Do Oncologists Respond to Clinical Trial Data? Oncologist, January 1, 2005; 10(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Holmes, M. Shevrin, B. Goldman, and D. Share Translating Research into Practice: Are Physicians Following Evidence-Based Guidelines in the Treatment of Hypertension? Med Care Res Rev, December 1, 2004; 61(4): 453 - 473. [Abstract] [PDF]
|
|
|
|
|
|
J. L. Milchak, B. L. Carter, P. A. James, and G. Ardery Measuring Adherence to Practice Guidelines for the Management of Hypertension: An Evaluation of the Literature Hypertension, November 1, 2004; 44(5): 602 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Stafford, C. D. Furberg, S. N. Finkelstein, I. M. Cockburn, T. Alehegn, and J. Ma Impact of Clinical Trial Results on National Trends in {alpha}-Blocker Prescribing, 1996-2002 JAMA, January 7, 2004; 291(1): 54 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Boulware, B. G. Jaar, M. E. Tarver-Carr, F. L. Brancati, and N. R. Powe Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis JAMA, December 17, 2003; 290(23): 3101 - 3114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Saseen, E. J. MacLaughlin, and J. M. Westfall Treatment of Uncomplicated Hypertension: Are ACE Inhibitors and Calcium Channel Blockers as Effective as Diuretics and {beta}-Blockers? J Am Board Fam Med, March 1, 2003; 16(2): 156 - 164. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hajjar, K. Miller, and V. Hirth Age-Related Bias in the Management of Hypertension: A National Survey of Physicians' Opinions on Hypertension in Elderly Adults J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2002; 57(8): M487 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Burt National Trends In Use Of Medications In Office-Based Practice, 1985-1999 Health Aff., July 1, 2002; 21(4): 206 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Balas, C. R. Nelson, and D. A. Knapp Trends in Antihypertensive Drug Therapy by US Office-Based Physicians Response Hypertension, May 1, 2001; 37 (5): e12 - e12. [Full Text] [PDF]
|
|